TEVA logo

TEVA Long term debt

Annual long term debt:

$16.30B-$2.18B(-11.81%)
December 31, 2024

Summary

  • As of today (May 31, 2025), TEVA annual long term debt is $16.30 billion, with the most recent change of -$2.18 billion (-11.81%) on December 31, 2024.
  • During the last 3 years, TEVA annual long term debt has fallen by -$5.74 billion (-26.03%).
  • TEVA annual long term debt is now -49.89% below its all-time high of $32.52 billion, reached on December 31, 2016.

Performance

TEVA Long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAbalance sheet metrics

Quarterly long term debt:

$16.52B+$220.00M(+1.35%)
March 31, 2025

Summary

  • As of today (May 31, 2025), TEVA quarterly long term debt is $16.52 billion, with the most recent change of +$220.00 million (+1.35%) on March 31, 2025.
  • Over the past year, TEVA quarterly long term debt has dropped by -$360.00 million (-2.13%).
  • TEVA quarterly long term debt is now -51.14% below its all-time high of $33.81 billion, reached on June 30, 2017.

Performance

TEVA Quarterly long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAbalance sheet metrics

Long term debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

TEVA Long term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-11.8%-2.1%
3 y3 years-26.0%-22.2%
5 y5 years-34.8%-33.6%

TEVA Long term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-26.0%at low-22.2%+1.4%
5 y5-year-34.8%at low-34.0%+1.4%
alltimeall time-49.9%>+9999.0%-51.1%>+9999.0%

TEVA Long term debt History

DateAnnualQuarterly
Mar 2025
-
$16.52B(+1.3%)
Dec 2024
$16.30B(-11.8%)
$16.30B(-2.4%)
Sep 2024
-
$16.70B(-0.8%)
Jun 2024
-
$16.83B(-0.3%)
Mar 2024
-
$16.88B(-8.7%)
Dec 2023
$18.48B(-5.0%)
$18.48B(-1.8%)
Sep 2023
-
$18.82B(-1.1%)
Jun 2023
-
$19.04B(-4.9%)
Mar 2023
-
$20.01B(+2.9%)
Dec 2022
$19.45B(-11.7%)
$19.45B(+3.2%)
Sep 2022
-
$18.85B(-9.1%)
Jun 2022
-
$20.73B(-2.4%)
Mar 2022
-
$21.23B(-3.6%)
Dec 2021
$22.03B(-5.1%)
$22.03B(+2.7%)
Sep 2021
-
$21.46B(-2.6%)
Jun 2021
-
$22.05B(-3.0%)
Mar 2021
-
$22.73B(-2.1%)
Dec 2020
$23.21B(-7.1%)
$23.21B(-3.2%)
Sep 2020
-
$23.99B(-4.2%)
Jun 2020
-
$25.03B(+0.6%)
Mar 2020
-
$24.88B(-0.5%)
Dec 2019
$25.00B(-6.4%)
$25.00B(+3.3%)
Sep 2019
-
$24.21B(-8.2%)
Jun 2019
-
$26.38B(+0.5%)
Mar 2019
-
$26.26B(-1.7%)
Dec 2018
$26.70B(-7.4%)
$26.70B(-0.4%)
Sep 2018
-
$26.82B(-7.4%)
Jun 2018
-
$28.96B(-1.6%)
Mar 2018
-
$29.45B(+2.2%)
Dec 2017
$28.83B(-11.4%)
$28.83B(-9.8%)
Sep 2017
-
$31.97B(-5.4%)
Jun 2017
-
$33.81B(+3.4%)
Mar 2017
-
$32.69B(+0.5%)
Dec 2016
$32.52B(+289.1%)
$32.52B(-2.0%)
Sep 2016
-
$33.18B(+312.9%)
Jun 2016
-
$8.04B(-6.8%)
Mar 2016
-
$8.62B(+3.1%)
Dec 2015
$8.36B(-2.4%)
$8.36B(-12.2%)
Sep 2015
-
$9.52B(+0.2%)
Jun 2015
-
$9.50B(+1.1%)
Mar 2015
-
$9.39B(+9.6%)
Dec 2014
$8.57B(-17.5%)
$8.57B(-2.9%)
Sep 2014
-
$8.82B(-3.3%)
Jun 2014
-
$9.12B(-11.0%)
Mar 2014
-
$10.24B(-1.4%)
Dec 2013
$10.39B(-11.3%)
$10.39B(+3.2%)
Sep 2013
-
$10.06B(+1.4%)
Jun 2013
-
$9.93B(-0.1%)
Mar 2013
-
$9.94B(-15.1%)
Dec 2012
$11.71B(+14.4%)
$11.71B(-7.7%)
Sep 2012
-
$12.69B(+0.5%)
Jun 2012
-
$12.63B(+24.3%)
Mar 2012
-
$10.16B(-0.8%)
Dec 2011
$10.24B(+149.1%)
$10.24B(+134.5%)
Sep 2011
-
$4.37B(+11.4%)
Jun 2011
-
$3.92B(-19.6%)
Mar 2011
-
$4.88B(+18.7%)
Dec 2010
$4.11B
$4.11B(-13.3%)
Sep 2010
-
$4.74B(-6.5%)
Jun 2010
-
$5.07B(+22.5%)
DateAnnualQuarterly
Mar 2010
-
$4.14B(-4.0%)
Dec 2009
$4.31B(-22.1%)
$4.31B(-13.3%)
Sep 2009
-
$4.97B(-7.5%)
Jun 2009
-
$5.37B(-5.8%)
Mar 2009
-
$5.70B(+3.0%)
Dec 2008
$5.54B(+65.4%)
$5.54B(+41.4%)
Sep 2008
-
$3.92B(+17.9%)
Jun 2008
-
$3.32B(-0.8%)
Mar 2008
-
$3.35B(+0.0%)
Dec 2007
$3.35B(-27.0%)
$3.35B(-0.3%)
Sep 2007
-
$3.36B(-15.6%)
Jun 2007
-
$3.98B(-0.6%)
Mar 2007
-
$4.01B(-12.6%)
Dec 2006
$4.58B(+158.6%)
$4.58B(-1.8%)
Sep 2006
-
$4.67B(+1.9%)
Jun 2006
-
$4.59B(-0.2%)
Mar 2006
-
$4.60B(+159.2%)
Dec 2005
$1.77B(+17.2%)
$1.77B(+17.2%)
Sep 2005
-
$1.51B(-0.0%)
Jun 2005
-
$1.51B(0.0%)
Mar 2005
-
$1.51B(+0.0%)
Dec 2004
$1.51B(+85.6%)
$1.51B(-12.5%)
Sep 2004
-
$1.73B(-7.2%)
Jun 2004
-
$1.86B(-1.9%)
Mar 2004
-
$1.90B(+133.0%)
Dec 2003
$815.40M(-29.8%)
$815.40M(+81.2%)
Sep 2003
-
$450.00M(-44.4%)
Jun 2003
-
$810.00M(-30.3%)
Mar 2003
-
$1.16B(+0.1%)
Dec 2002
$1.16B(-6.9%)
$1.16B(-7.4%)
Sep 2002
-
$1.25B(-1.8%)
Jun 2002
-
$1.28B(+2.0%)
Mar 2002
-
$1.25B(+0.4%)
Dec 2001
$1.25B(+53.2%)
$1.25B(-0.2%)
Sep 2001
-
$1.25B(+55.9%)
Jun 2001
-
$801.93M(-0.6%)
Mar 2001
-
$806.61M(-0.9%)
Dec 2000
$813.89M(+107.9%)
$813.89M(+120.9%)
Jun 2000
-
$368.37M(-5.2%)
Mar 2000
-
$388.77M(-0.7%)
Dec 1999
$391.42M(+94.1%)
$391.42M(+27.0%)
Sep 1999
-
$308.30M(+51.4%)
Jun 1999
-
$203.60M(+1.1%)
Mar 1999
-
$201.30M(-0.2%)
Dec 1998
$201.70M(+55.3%)
$201.70M(-0.2%)
Sep 1998
-
$202.10M(+0.9%)
Jun 1998
-
$200.30M(+77.1%)
Mar 1998
-
$113.10M(-12.9%)
Dec 1997
$129.90M(-19.4%)
$129.90M(-19.4%)
Dec 1996
$161.10M(+72.9%)
$161.10M(+72.9%)
Dec 1995
$93.20M(+15.3%)
$93.20M(+15.3%)
Dec 1994
$80.80M(+16.6%)
$80.80M(+16.6%)
Dec 1993
$69.30M(+87.3%)
$69.30M(+87.3%)
Dec 1992
$37.00M(-36.1%)
$37.00M(-36.1%)
Dec 1991
$57.90M(-15.6%)
$57.90M(-15.6%)
Dec 1990
$68.60M(+3.2%)
$68.60M(+3.2%)
Dec 1989
$66.50M(+66.7%)
$66.50M(+66.7%)
Dec 1988
$39.90M(+88.2%)
$39.90M(+88.2%)
Mar 1987
$21.20M(-15.5%)
$21.20M(-15.5%)
Mar 1986
$25.10M
$25.10M

FAQ

  • What is Teva Pharmaceutical Industries Limited annual long term debt?
  • What is the all time high annual long term debt for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual long term debt year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly long term debt?
  • What is the all time high quarterly long term debt for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly long term debt year-on-year change?

What is Teva Pharmaceutical Industries Limited annual long term debt?

The current annual long term debt of TEVA is $16.30B

What is the all time high annual long term debt for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual long term debt is $32.52B

What is Teva Pharmaceutical Industries Limited annual long term debt year-on-year change?

Over the past year, TEVA annual long term debt has changed by -$2.18B (-11.81%)

What is Teva Pharmaceutical Industries Limited quarterly long term debt?

The current quarterly long term debt of TEVA is $16.52B

What is the all time high quarterly long term debt for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly long term debt is $33.81B

What is Teva Pharmaceutical Industries Limited quarterly long term debt year-on-year change?

Over the past year, TEVA quarterly long term debt has changed by -$360.00M (-2.13%)
On this page